Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
NOAH is an investigator-initiated, prospective, parallel-group, double-blind, randomised, multi-centre trial. The objective of the trial is to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy to pre-vent stroke, systemic embolism, or cardiovascular death in patients with AHRE and at least two stroke risk factors but without AF. The trial will be conducted in several European countries.
Epistemonikos ID: a9d5d1c6b3a17177309ca9716c2f13d73f4fd694
First added on: May 12, 2024